Welcome to LookChem.com Sign In|Join Free
  • or
Potassium piperidine-1-dithiocarboxylate is a chemical compound with the molecular formula C8H14KNS2. It is a salt of piperidine-1-dithiocarboxylic acid and is known for its ability to form complexes with various metal ions. This property makes it useful in analytical chemistry, metal extraction processes, and as a reagent in organic synthesis and the preparation of metal sulfides. Furthermore, it has been studied for its potential applications in anti-cancer and anti-inflammatory treatments due to its ability to inhibit certain enzymes and pathways involved in these conditions.

136-04-9

Post Buying Request

136-04-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

136-04-9 Usage

Uses

Used in Organic Synthesis:
Potassium piperidine-1-dithiocarboxylate is used as a reagent in organic synthesis for its ability to form complexes with metal ions, which aids in various chemical reactions.
Used in Preparation of Metal Sulfides:
In the preparation of metal sulfides, potassium piperidine-1-dithiocarboxylate is used as a reagent to facilitate the formation of these compounds.
Used in Analytical Chemistry:
In analytical chemistry, potassium piperidine-1-dithiocarboxylate is used for its complex-forming ability with metal ions, which helps in the analysis and detection of these elements.
Used in Metal Extraction Processes:
In metal extraction processes, potassium piperidine-1-dithiocarboxylate is used to form complexes with metal ions, aiding in the separation and extraction of metals from their ores.
Used in Medicinal Chemistry Anti-cancer Treatments:
Potassium piperidine-1-dithiocarboxylate is studied for use as an anti-cancer agent due to its potential to inhibit enzymes and pathways involved in cancer development.
Used in Medicinal Chemistry Anti-inflammatory Treatments:
potassium piperidine-1-dithiocarboxylate is also being studied for its potential use in anti-inflammatory treatments, as it may inhibit certain enzymes and pathways associated with inflammation.

Check Digit Verification of cas no

The CAS Registry Mumber 136-04-9 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,3 and 6 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 136-04:
(5*1)+(4*3)+(3*6)+(2*0)+(1*4)=39
39 % 10 = 9
So 136-04-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H11NS2.K/c8-6(9)7-4-2-1-3-5-7;/h1-5H2,(H,8,9);/q;+1/p-1

136-04-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name potassium,piperidine-1-carbodithioate

1.2 Other means of identification

Product number -
Other names potassium piperidinedithiocarbamate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:136-04-9 SDS

136-04-9Relevant academic research and scientific papers

Synthesis and antitumor activity of tetrahydrocarbazole hybridized with dithioate derivatives

El-Nassan, Hala Bakr

, p. 308 - 315 (2015)

The present study reported the synthesis of tetrahydrocarbazoles hybridized with dithioate derivatives. Three series were synthesized namely alkyl dithiocarbonates (4a-d), heterocyclic dithiocarbamates (6a-g) and dialkyl dithiocarbamate (7). The synthesized compounds were tested in vitro on human breast adenocarcinoma cell line (MCF7) and the human colon tumor cell line (HCT116). Most of the synthesized compounds exploited potent antitumor activity, especially compound 6f [4-chlorophenylpiperazine derivative], which showed cytotoxic activity against MCF7 superior to doxorubicin with IC50 value of 7.24 nM/mL.

Synthesis and antimicrobial activities of some 1-[(N,N- disubstitutedthiocarbamoylthio)acetyl]-3,5-diaryl-2-pyrazolines

Turan-Zitouni, Guelhan,Oezdemir, Ahmet,Kaplancikli, Zafer Asim,Chevallet, Pierre,Tunali, Yagmur

, p. 2717 - 2724 (2005)

The increasing clinical importance of drug-resistant fungal and bacterial pathogens has lent additional urgency to microbiological research and new antimicrobial compound development. For this purpose, new pyrazoline derivatives were synthesized and evaluated for antimicrobial activity. Some 1-[(N,N-disubstitutedthiocarbamoylthio)acetyl]-3,5-diaryl-2-pyrazolines derivatives were synthesized by reacting 1-(chloroacetyl)-3,5-diaryl-2- pyrazolines with appropriate potassium salts of secondary amine dithiocarbamic acids. The chemical structures of the compounds were elucidated by IR, 1H-NMR, and FAB+-MS spectral data. Their antimicrobial activities against Staphylococcus aureus (B-767), Escherichia coli (B-3704), Pseudomonas aeruginosa (ATCC 27853), Proteus vulgaris (NRLL B-123), and Candida albicans (NRRL-27077) were investigated. The results showed that some of the compounds have notable activity against S. aureus and C. albicans. Copyright Taylor & Francis Inc.

Gold(Iii) to ruthenium(iii) metal exchange in dithiocarbamato complexes tunes their biological mode of action for cytotoxicity in cancer cells

Brustolin, Leonardo,Dalla Pozza, Maria,Fregona, Dolores,Gaiddon, Christian,Nardon, Chiara,Orvain, Christophe,Pettenuzzo, Nicolò

, (2021)

Malignant tumors have affected the human being since the pharaoh period, but in the last century the incidence of this disease has increased due to a large number of risk factors, including deleterious lifestyle habits (i.e., smoking) and the higher longevity. Many efforts have been spent in the last decades on achieving an early stage diagnosis of cancer, and more effective cures, leading to a decline in age-standardized cancer mortality rates. In the last years, our research groups have developed new metal-based complexes, with the aim to obtain a better selectivity for cancer cells and less side effects than the clinically established reference drug cisplatin. This work is focused on four novel Au(III) and Ru(III) complexes that share the piperidine dithiocarbamato (pipe-DTC) as the ligand, in a different molar ratio. The compounds [AuCl2(pipeDTC)], [Au(pipeDTC)2]Cl, [Ru(pipeDTC)3] and β-[Ru2(pipeDTC)5] have been synthesized and fully characterized by several chemical analyses. We have then investigated their biological properties in two different cell lines, namely, AGS (gastric adenocarcinoma) and HCT116 (colon carcinomas), showing significant differences among the four compounds. First, the two gold-based compounds and β-[Ru2(pipeDTC)5] display IC50 in the μM range, significantly lower than cisplatin. Second, we showed that [AuCl2(pipeDTC)] and β-[Ru2(pipeDTC)5]Cl drive different molecular mechanisms. The first was able to induce the protein level of the DNA damage response factor p53 and the autophagy protein p62, in contrast to the second that induced the ATF4 protein level, but repressed p62 expression. This study highlights that the biological activity of different complexes bringing the same organic ligand depends on the electronic and structural properties of the metal, which are able to fine tune the biological properties, giving us precious information that can help to design more selective anticancer drugs.

Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes

Brustolin,Nardon,Pettenuzzo,Zuin Fantoni,Quarta,Chiara,Gambalunga,Trevisan,Marchiò,Pontisso,Fregona

, p. 15477 - 15486 (2018)

In this paper, we focused on the analysis of the effects mediated by different cyclic dithiocarbamic ligands (DTC) on three classes of antiproliferative coordination compounds, namely, Ru(iii) complexes with the general formulae [Ru(DTC)3] and [Ru2(DTC)5]Cl, and the neutral Cu(ii) derivatives of the type [Cu(DTC)2]. In particular, we present the synthesis and characterization of a library of total 23 coordination compounds containing Ru(iii) or Cu(ii) as the biologically-active metal center and two or more dithiocarbamato (DTC) ligands derived from cyclic amines (aliphatic or aromatic). Several techniques including elemental analysis, X-ray crystallography, ESI-MS, 1H-NMR spectroscopy, FT-IR and UV-Vis spectrophotometry were used to characterize the compounds, which highlighted the different electronic behaviors generated by the substituents within the DTC moiety. Moreover, the synthesized compounds were tested for their stability in order to investigate their antiproliferative activity against 3 human cancer cell lines, namely, HeLa, HepG2 and HepG2/SB3. In particular, HepG2/SB3 was chosen for its aggressiveness due to upregulation of the anti-apoptotic protein SerpinB3. Finally, the most promising compounds are studied in terms of log?P. Overall, the results reveal the drug-likeness of some of the derivatives of copper(ii) and ruthenium(iii).

Multicomponent reaction of amine, carbon disulfide, and fluoronitrobenzene via nucleophilic attack on the fluorinated carbon for the synthesis of nitrophenyl methylcarbamodithioates

Bahadorikhalili, Saeed,Mohammadi, Sayyad,Asadi, Mehdi,Barazandeh, Maliheh,Mahdavi, Mohammad

, p. 160 - 164 (2020)

In this paper, multicomponent reaction of amine, carbon disulfide and fluoronitrobenzene is reported for the synthesis of nitrophenyl methylcarbamodithioate derivatives. The method is based on the nucleophilic attack of the activated methylcarbamodithioate salt to fluoronitrobenzene. Several starting materials are tested and successfully produced the corresponding nitrophenyl methylcarbamodithioate. A possible mechanism for the reaction is suggested.

Synthesis, characterization and in-vitro antifungal evaluation of some dithiocarbamic acid derivatives

Mahfouz, Nadia M.,Moharram, Ahmad M.

, p. 315 - 322 (1999)

Some new N, N-disubstituted dithiocarbamates derived from α-acetonaphthone and their precursors, potassium salts of dithiocarbamic acid, were prepared and evaluated for antifungal activity. Synthesis involved the reaction of α-chloro-2-acetonaphthone or α-chloro-4-methoxy-1-acetonaphthone with the potassium salts of N, N-disubstituted dithiocarbamic acid (5a-g). Compounds 5a-g were readily produced by reaction of equivalent amounts of the appropriate secondary amine, potassium hydroxide and carbon disulphide. The purity of the final derivatives, N, N-disubstituted dithiocarbamates 6a-g and 7a-g, was determined elemental analyses and TLC, and assignment of structures was confirmed by IR, 1H NMR, 13C NMR and MS. Preliminary evaluation of the antifungal activity of derivatives 5a-g, 6a-g and 7a-g was determined in-vitro at a 2.5 or 5.0% concentration against different fungal species using tolnaftate as a reference drug. The potassium salts 5a-g were the most potent derivatives of the tested series. Compounds 5a-g showed significant broad spectrum antifungal activity. Combination of the dithiocarbamate with acetonaphthonyl moiety, represented by the 6a-g and 7a-g series, resulted in a decrease in or complete loss of antifungal activity in certain derivatives. Compounds derived from 4-methoxy-1-acetonaphthone (7a-g) were generally superior to their 4-nonsubstituted congeners (6a-g). The morpholino dithiocarbamate derivative 7e was equipotent or superior to the reference drug against the tested dermatophytes species and Rhodotorula rubra at a 5% concentration. In addition, 7e exhibited inhibitory activity against Chrysosporium tropicum, Emericella nidulans, Penicillium aurantiogriseum and Aspergillus sydowii. Some derivatives of both series showed selective activity against certain fungi, (e.g. 6f against Phoma glomerata and Scopulariopsis acremonium; 6g against Emericella nidulans and Phoma glomerata; 7c against Geotrichum candidum and Mucor circinelloides; 7d against Geotrichum candidum, Penicillium aurantiogriseum and Rodotorula rubra and 7f against Mucor circinelloides).

Disulfiram as a potent metallo-β-lactamase inhibitor with dual functional mechanisms

Chen, Cheng,Li, Jia-Qi,Sun, Le-Yun,Wu, Lin-Yu,Yang, Ke-Wu

supporting information, p. 2755 - 2758 (2020/03/17)

We report a promising NDM-1 inhibitor, disulfiram, which can covalently bind to NDM-1 by forming an S-S bond with the Cys208 residue. Its copper-containing metabolite in vivo, Cu(DTC)2, also inactivated NDM-1 through oxidizing the Zn(ii) thiolate site of the enzyme, therefore exhibiting dual functional inhibitory potential against B1 and B2 subclass MβLs.

Discovery and optimization of novel dual dithiocarbamates as potent anticancer agents

Li, Ri-Dong,Wang, Hui-Ling,Li, Ying-Bo,Wang, Zhong-Qing,Wang, Xin,Wang, Yi-Tao,Ge, Ze-Mei,Li, Run-Tao

, p. 381 - 391 (2015/03/04)

A series of dual dithiocarbamates were synthesized and evaluated for their in-vitro anticancer activities on human non-small cell lung cancer cell line H460. Nine compounds exhibited significant antiproliferative activities with IC50 less than 1 μM. Among them, compound 14m showed the highest inhibitory activity against H460 cell and inhibited the growth of nine types of tumor cells with IC50 values less than 1 μM. It also achieved IC50 of 54 nM and 23 nM against HepG2 and MCF-7 cell lines, respectively. Preliminary structure-activity relationship study indicated that: a) when the methyl group (region A) is substituted with benzene rings, ortho substitution on the benzene ring is favored for activity; b) substitution with heterocyclic structures at region A exhibited greater impact on the anti-tumor activity of compounds, in which pyridine ring, thiazole ring, coumarin and benzo[b]thiophene are favored and quinoline ring is the most favored; c) substitution with different amines (region B) also showed marked effect on the activity of compounds and dimethylamine and morpholine are preferred to other tested amines.

Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors

Kapanda, Coco N.,Muccioli, Giulio G.,Labar, Geoffray,Poupaert, Jacques H.,Lambert, Didier M.

experimental part, p. 7310 - 7314 (2010/07/14)

Monoglyceride lipase (MGL) inhibition may offer an approach in treating diseases in which higher 2-arachidonoyglycerol activity would be beneficial. We report here the synthesis and pharmacological evaluation of bis(dialkylaminethiocarbonyl)disulfide derivatives as irreversible MGL inhibitors. Inhibition occurs through interactions with MGL C208 and C242 residues, and these derivatives exhibit high inhibition selectivity over fatty acid amide hydrolase, another endocannabinoid-hydrolyzing enzyme. 2009 American Chemical Society.

Synthesis and anticonvulsant activity of some new hexahydropyrimidine-2,4- dione derivatives

Septioglu, Ebubekir,Aytemir, Mutlu Dilsiz,Calis, Uensal

, p. 259 - 264 (2007/10/03)

In this study, twelve new hexahydropyrimidine-2,4-dione derivatives were synthesized and screened for their anticonvulsant activities. All the compounds (7a-l) which have 6-arylhexahydropyrimidine-2,4-dione and N,N-disubstituted dithiocarbamate structures were prepared by the reaction with appropriate 3-(2-chloroethyl)-6-arylhexahydropyrimidine-2,4-diones and the corresponding N,N-disubstituted dithiocarbamate potassium salts. The structure of the synthesized compounds was confirmed by UV, IR, 1H-NMR and elemental analysis. Their anticonvulsant activities were determined by maximal electroshock (MES), subcutaneous pentetrazol (metrazol, scMet) and rotorod toxicity tests for neurological deficits. According to the activity studies, 6-(4-chlorophenyl)hexahydropyrimidine-2,4-dione derivatives (7e-h) were found to be highly protective against MES and scMet. Neurotoxicity was not observed in any of the tested compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 136-04-9